Waiting on Isomorphic’s AI ambition, California’s $8.4 billion research measure, and more biotech news
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
I might have been just as unblinking as Elizabeth during the three hours of “You Can See Everything.” Seats-edge viewing experience. What did you think?
Also: We’ll be in Madrid later this week for the European Society for Medical Oncology’s annual meeting, and we’ll be penning an ESMO in 30 Seconds newsletter. Sign up here.
STAT+ Exclusive Story
Already have an account? Log in
This article is exclusive to STAT+ subscribers
Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.
Already have an account? Log in
To read the rest of this story subscribe to STAT+.
-
Meghana Keshavan covers biotech and contributes to The Readout newsletter.
